Genprex
GNPX
28 hedge funds and large institutions have $15.8M invested in Genprex in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
13% less funds holding
Funds holding: 32 → 28 (-4)
19% less capital invested
Capital invested by funds: $19.5M → $15.8M (-$3.7M)
22% less call options, than puts
Call options by funds: $648K | Put options by funds: $835K
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.17M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$388K |
| 3 |
CC
Cypress Capital
Franklin,
Tennessee
|
+$259K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$259K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$518K |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$363K |
| 3 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$319K |
| 4 |
Morgan Stanley
New York
|
-$259K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$259K |
GNPX Hedge Fund Activity: Q3 2021 in Review
28 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2021, worth a combined $15.8M — down 19% from $19.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNPX and 6 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $1.17M. The largest seller was Millennium Management, cutting an estimated $518K.
- 28 institutional investors held Genprex (GNPX) as of Q3 2021, down from 32 in Q2 2021.
- Funds reported $15.8M of Genprex stock for Q3 2021, down 19% quarter-over-quarter.
- 6 funds opened new Genprex positions in Q3 2021 and 10 closed out, a net change of -4 holders.
- The largest Genprex buyer in Q3 2021 was GSA Capital Partners, an estimated $1.17M added.
- The largest Genprex seller in Q3 2021 was Millennium Management, an estimated $518K sold.
Based on aggregated 13F filings for Q3 2021.